Everbright Securities
Richard Wang is a Medical Industry Analyst with extensive experience in the pharmaceutical sector, currently working at 光大证券 since March 2018, focusing on biological medicine and innovative drugs. Richard’s previous roles include internships as a Medical Industry Analyst at China Asset Management Co., Ltd. and DongXing Securities Ltd., where research involved creating drug databases and analyzing the internationalization of pharmaceutical companies. Richard also conducted studies on the exportation of pharmaceuticals at China Galaxy Securities Co., LTD and began a career in marketing at Zhijianyi Culture Media Co., Ltd. Richard holds a Master of Science in chemicobiology and a Bachelor of Science in Pharmaceutical from Peking University.
This person is not in the org chart
This person is not in any teams
Everbright Securities
Everbright Securities Company Limited is a China-based company principally engaged in the securities broking businesses. The Company mainly operates through six business segments. The Brokerage and Wealth Management segment is mainly engaged in the trading of stocks, funds, bonds, futures, options and other securities. The Credit Businesses segment is mainly engaged in margin financing and securities lending, repurchase transactions and others. The Institutional Securities Services segment is engaged in investment banking, sales and trading, investment research and prime brokerage. The Investment Management segment is engaged in providing asset management, fund management and private equity investment management services. The Overseas Businesses segment is mainly engaged in the wealth management, investment banking and asset management, among others.